• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cytoreduction and Heated Intraperitoneal Chemotherapy in Gastric Peritoneal Carcinomatosis: Selection is Key.

作者信息

Senthil Maheswari, Dayyani Farshid

机构信息

Division of Surgical Oncology, University of California-Irvine, Orange, CA, USA.

Division of Hematology and Oncology, University of California-Irvine, Orange, CA, USA.

出版信息

Ann Surg Oncol. 2024 Dec;31(13):8491-8493. doi: 10.1245/s10434-024-16336-z. Epub 2024 Oct 12.

DOI:10.1245/s10434-024-16336-z
PMID:39394488
Abstract
摘要

相似文献

1
Cytoreduction and Heated Intraperitoneal Chemotherapy in Gastric Peritoneal Carcinomatosis: Selection is Key.细胞减灭术与热灌注腹腔化疗治疗胃腹膜癌转移：关键在于选择。
Ann Surg Oncol. 2024 Dec;31(13):8491-8493. doi: 10.1245/s10434-024-16336-z. Epub 2024 Oct 12.
2
Optimizing outcomes for patients with gastric cancer peritoneal carcinomatosis.优化胃癌腹膜转移患者的治疗结局。
World J Gastrointest Oncol. 2018 Oct 15;10(10):282-289. doi: 10.4251/wjgo.v10.i10.282.
3
Prophylaxis and treatment of peritoneal carcinomatosis of gastric origin using hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis of randomized trials.采用腹腔内热化疗预防和治疗胃源性腹膜癌转移：一项随机试验的系统评价和荟萃分析。
J Gastrointest Surg. 2024 Jul;28(7):1185-1193. doi: 10.1016/j.gassur.2024.04.007. Epub 2024 Apr 8.
4
Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study.胃癌患者腹膜播散的细胞减灭术和腹腔内热灌注化疗（HIPEC）治疗：PERISCOPE研究的原理与设计
JMIR Res Protoc. 2017 Jul 13;6(7):e136. doi: 10.2196/resprot.7790.
5
Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.细胞减灭术及围手术期腹腔内化疗作为腹膜假黏液瘤综合征的一种根治性治疗方法。
Eur J Surg Oncol. 2001 Apr;27(3):239-43. doi: 10.1053/ejso.2000.1038.
6
Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic features.结直肠癌腹膜转移瘤细胞减灭术及腹腔内化疗后的二次探查手术：预后特征分析
World J Surg. 1999 Jan;23(1):23-9. doi: 10.1007/s002689900560.
7
Regional Therapy Approaches for Gastric Cancer with Limited Peritoneal Disease.局限性腹膜疾病胃癌的区域治疗方法。
J Gastrointest Cancer. 2024 Jun;55(2):534-548. doi: 10.1007/s12029-023-00994-5. Epub 2024 Jan 26.
8
[Peritoneal carcinomatosis of gastric cancer : Treatment options for peritoneal carcinomatosis of gastric cancer].[胃癌腹膜转移癌：胃癌腹膜转移癌的治疗选择]
Chirurgie (Heidelb). 2022 Dec;93(12):1133-1138. doi: 10.1007/s00104-022-01699-4. Epub 2022 Aug 18.
9
The history of cytoreduction and HIPEC: Heating up or just blowing smoke?细胞减灭术与腹腔热灌注化疗的历史：是升温还是只是空谈？
J Surg Oncol. 2024 Oct;130(5):1130-1138. doi: 10.1002/jso.27802. Epub 2024 Nov 3.
10
Survival outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from gastric cancer: a systematic review.胃癌腹膜转移行细胞减灭术和腹腔热灌注化疗后的生存结局：一项系统评价
Pleura Peritoneum. 2016 Jun 1;1(2):67-77. doi: 10.1515/pp-2016-0010. Epub 2016 Jun 9.

引用本文的文献

1
Iterative Intraperitoneal Chemotherapy in Gastric Cancer Peritoneal Carcinomatosis.胃癌腹膜转移的迭代腹腔内化疗
Cancers (Basel). 2025 Jan 17;17(2):289. doi: 10.3390/cancers17020289.

本文引用的文献

1
The Role of Metastasectomy in Patients with Liver-Only Metastases from Gastric Adenocarcinoma.胃腺癌仅肝转移患者中肝转移瘤切除术的作用
Ann Surg Oncol. 2025 Jan;32(1):391-398. doi: 10.1245/s10434-024-16318-1. Epub 2024 Sep 30.
2
First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial.纳武利尤单抗联合化疗一线治疗晚期胃/胃食管结合部和食管腺癌：III 期 CheckMate 649 试验的 3 年随访结果。
J Clin Oncol. 2024 Jun 10;42(17):2012-2020. doi: 10.1200/JCO.23.01601. Epub 2024 Feb 21.
3
Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial.
Zolbetuximab 联合 CAPOX 方案治疗 Claudin18.2 阳性胃或胃食管结合部腺癌：一项随机、III 期 GLOW 试验
Nat Med. 2023 Aug;29(8):2133-2141. doi: 10.1038/s41591-023-02465-7. Epub 2023 Jul 31.
4
Phase II clinical trial of sequential treatment with systemic chemotherapy and intraperitoneal paclitaxel for gastric and gastroesophageal junction peritoneal carcinomatosis - STOPGAP trial.胃癌和胃食管结合部腹膜转移患者行全身化疗序贯腹腔紫杉醇治疗的 II 期临床试验——STOPGAP 试验。
BMC Cancer. 2023 Mar 4;23(1):209. doi: 10.1186/s12885-023-10680-1.
5
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial.一线纳武利尤单抗联合化疗与单纯化疗治疗晚期胃癌、胃食管交界癌和食管腺癌（CheckMate 649）：一项随机、开放标签的3期试验。
Lancet. 2021 Jul 3;398(10294):27-40. doi: 10.1016/S0140-6736(21)00797-2. Epub 2021 Jun 5.
6
Poor perfusion of the microvasculature in peritoneal metastases of ovarian cancer.卵巢癌腹膜转移中的微血管灌注不良。
Clin Exp Metastasis. 2020 Apr;37(2):293-304. doi: 10.1007/s10585-020-10024-4. Epub 2020 Feb 1.
7
Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis.细胞减灭术联合或不联合腹腔热灌注化疗治疗胃癌腹膜转移（CYTO-CHIP 研究）：倾向评分分析。
J Clin Oncol. 2019 Aug 10;37(23):2028-2040. doi: 10.1200/JCO.18.01688. Epub 2019 May 14.
8
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II).细胞减灭术和腹腔热灌注化疗与姑息性全身化疗治疗胃癌伴腹膜转移患者的比较：一项多中心随机对照试验（PERISCOPE II）研究方案。
BMC Cancer. 2019 May 6;19(1):420. doi: 10.1186/s12885-019-5640-2.
9
The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI.RENAISSANCE (AIO-FLOT5) 试验：单纯化疗与化疗后手术切除对局限转移性胃或胃食管交界部腺癌患者生存和生活质量的影响——德国 AIO/CAO-V/CAOGI 多中心、开放标签、III 期临床试验
BMC Cancer. 2017 Dec 28;17(1):893. doi: 10.1186/s12885-017-3918-9.
10
Peritoneal-plasma barrier.腹膜-血浆屏障
Cancer Treat Res. 1996;82:53-63. doi: 10.1007/978-1-4613-1247-5_4.